Prevention of pericyte loss by trolox in diabetic rat retina.

Prolonged hyperglycemia results in a number of diabetic complications, including retinopathy. Pericyte degeneration is one of the earliest histological changes observed in the development of diabetic retinopathy. Increased free radicals generated under hyperglycemia could damage the retina, which abounds in polyunsaturated fatty acids. In the current study, a severalfold increase in thiobarbituric acid-reactive substances was found in rat retina cultured in hyperglycemic medium, which decreased significantly when trolox, an amphipathic antioxidant, was included in the medium. To examine the contribution of oxidative stress in vivo, diabetic rats were fed trolox (0.4% in the diet) during the course of the experiments. After 5 mo of hyperglycemia, whole mounts of retinal vessels were prepared and endothelial cells (E) and pericytes (P) were counted. The ratio of E/P in the retinas obtained from normal rats, diabetic rats, and diabetic rats fed trolox were 1.74 +/- 0.186, 3.78 +/- 0.47, and 2.32 +/- 0.24, respectively. A significant restoration of pericytes by trolox suggests the involvement of oxidative injury during pericyte loss in diabetic retinopathy.

[1]  A. Benedetti,et al.  Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. , 1980, Biochimica et biophysica acta.

[2]  G. Horton,et al.  Flat-mount studies of human retinal vessels. , 1966, American journal of ophthalmology.

[3]  D. Archer,et al.  A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. , 1985, American journal of ophthalmology.

[4]  N. Ansari,et al.  Role of lipid aldehydes in cataractogenesis: 4-hydroxynonenal-induced cataract. , 1996, Biochemical and molecular medicine.

[5]  E. Stadtman,et al.  Quantitation of 4-hydroxynonenal protein adducts. , 1994, Methods in enzymology.

[6]  D. Cogan,et al.  Studies of Retinal Vascular Patterns: Part I. Normal Architecture , 1960 .

[7]  S P Wolff,et al.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. , 1987, The Biochemical journal.

[8]  R. Anderson,et al.  Lipids of ocular tissues. IV. A comparison of the phospholipids from the retina of six mammalian species. , 1970, Experimental Eye Research.

[9]  D. Armstrong,et al.  Studies on experimentally induced retinal degeneration. 1. Effect of lipid peroxides on electroretinographic activity in the albino rabbit. , 1982, Experimental eye research.

[10]  W. Robison.  Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors. , 1988, Advances in experimental medicine and biology.

[11]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[12]  S. Bursell,et al.  Normalization of Diacylglycerol-Protein Kinase C Activation by Vitamin E in Aorta of Diabetic Rats and Cultured Rat Smooth Muscle Cells Exposed to Elevated Glucose Levels , 1994, Diabetes.

[13]  B. P. Yu,et al.  Lipid peroxidation contributes to age-related membrane rigidity. , 1995, Free radical biology & medicine.

[14]  K. Katoh.  Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus. , 1992, Diabetes research and clinical practice.

[15]  A. A. Spector,et al.  Fatty acid and lipid composition of the monkey retina in diet-induced hypercholesterolemia. , 1981, Atherosclerosis.

[16]  M. Brownlee,et al.  Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. , 1990, Biochemical and biophysical research communications.

[17]  D. Armstrong,et al.  Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. , 1991, Free radical biology & medicine.

[18]  B. Yu,et al.  Alterations in mitochondrial membrane fluidity by lipid peroxidation products. , 1994, Free radical biology & medicine.

[19]  H. Esterbauer,et al.  Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. , 1993, Mutation research.

[20]  L. Barclay,et al.  Partitioning and antioxidant action of the water-soluble antioxidant, Trolox, between the aqueous and lipid phases of phosphatidylcholine membranes: 14C tracer and product studies. , 1995, Biochimica et biophysica acta.

[21]  C. Kilo,et al.  Regional variations in the width of the basement membrane of muscle capillaries in man and giraffe. , 1971, The American journal of pathology.

[22]  A. Cerami,et al.  Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. , 1986, Science.

[23]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[24]  T. W. Wu,et al.  Trolox protects rat hepatocytes against oxyradical damage and the ischemic rat liver from reperfusion injury , 1991, Hepatology.

[25]  T. Kern,et al.  Abnormalities of Retinal Metabolism in Diabetes or Experimental Galactosemia. III. Effects of Antioxidants , 1996, Diabetes.

[26]  B. Goldstein,et al.  Effects of alpha, beta-unsaturated aldehydes on macrophage and neutrophil membrane function, fluidity and sulfhydryl status. , 1988, Basic life sciences.

[27]  R. Hamilton,et al.  4-Hydroxynonenal-induced cell death in murine alveolar macrophages. , 1996, Toxicology and applied pharmacology.

[28]  T. Nishida,et al.  Lipid peroxidation in diabetic rat retina. , 1981, Metabolic and pediatric ophthalmology.

[29]  R. Dean,et al.  Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. , 1988, The Biochemical journal.

[30]  J. Kinoshita,et al.  Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. , 1983, Science.